Cargando…
Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line.
Photodynamic therapy is a method for treating cancer using drugs activated by light. A new compound, 5-aminolaevulinic acid (ALA), is a precursor of the active photosensitizer protoporphyrin IX (PpIX) and has fewer side-effects and much more transient phototoxicity than previous photosensitizers. Ce...
Autores principales: | Datta, S. N., Allman, R., Loh, C., Mason, M., Matthews, P. N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2224056/ https://www.ncbi.nlm.nih.gov/pubmed/9252197 |
Ejemplares similares
-
Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.
por: van Geel, I. P., et al.
Publicado: (1995) -
Enhancement of photodynamic therapy by mitomycin C: a preclinical and clinical study.
por: Baas, P., et al.
Publicado: (1996) -
Effectiveness of an Immediate Mitomycin C Instillation in Patients with Superficial Bladder Cancer Receiving Periodic Mitomycin C Instillation
por: Jung, Seok Jin, et al.
Publicado: (2011) -
Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma.
por: Ma, L. W., et al.
Publicado: (1995) -
Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Chong, G, et al.
Publicado: (2005)